GenusPlus Group Limited
GNSPF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | -$0 | -$0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 33.6% | -31.6% | 20.5% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 113.5% | 11.9% | 74.5% | 10.6% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 9.7% | 11.2% | 7.4% | 5.4% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 5.2% | 4.1% | 3.4% | 3.6% |
| EPS Diluted | 0.078 | 0.047 | 0.056 | 0.051 |
| % Growth | 66% | -15.7% | 9% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |